(European Society of Cardiology) In contrast to European and American guidelines that recommend pre-hospital antiplatelet therapy for heart attack patients suffering from ST-elevation myocardial infarction (STEMI), a new study presented at ESC Congress suggests this practice has no advantage over waiting for in-hospital treatment.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2xtP4AQ
No comments:
Post a Comment